Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy

Jeļena Eglīte; Diāna Kasjko; Vladislavs Jasinskis; Elvīra Hagina; Inga Januškeviča; Gunta Stūre; Baiba Rozentāle; Jeļena Storoženko; Ludmila Vīksna

Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy

Translated title of the contribution: Ar HIV inficētas mātes intrauterīnas augļa HIV inficēšanās prognozēšanas paņēmiens pirmajos sešos grūtniecības mēnešos

Jeļena Eglīte (Inventor), Diāna Kasjko (Inventor), Vladislavs Jasinskis (Inventor), Elvīra Hagina (Inventor), Inga Januškeviča (Inventor), Gunta Stūre (Inventor), Baiba Rozentāle (Inventor), Jeļena Storoženko (Inventor), Ludmila Vīksna (Inventor)

Rīga Stradiņš University

Research output: Intellectual property › Patent

Abstract

Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin
HIV infection in foetuses during the first six months of pregnancy. The method provides for detection of TNFα, IL2, IL4, IL12β, IL10, INFɣ mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.

Translated title of the contribution	Ar HIV inficētas mātes intrauterīnas augļa HIV inficēšanās prognozēšanas paņēmiens pirmajos sešos grūtniecības mēnešos
Original language	Latvian
Patent number	15 133
IPC	G01N33/53,GO1N33/543
Priority date	9/03/16
Filing date	9/03/16
Publication status	Published - 20 Jan 2017

Keywords*

prognosing risk of intrauterin HIV infection

Field of Science*

3.2 Clinical medicine

Patent expiration date

01.10.2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://databases.lrpv.gov.lv/databases/lv/patent/details/p-16-14/

Cite this

Eglīte, J., Kasjko, D., Jasinskis, V., Hagina, E., Januškeviča, I., Stūre, G., Rozentāle, B., Storoženko, J., & Vīksna, L. (2017). Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy. (Patent No. 15 133). Patent Office of the Republic of Latvia. http://databases.lrpv.gov.lv/databases/lv/patent/details/p-16-14/

@misc{09eac63fdbc94a3c9c56f28baea1c054,

title = "Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy",

abstract = "Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy. The method provides for detection of TNFα, IL2, IL4, IL12β, IL10, INFɣ mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.",

keywords = "prognosing risk of intrauterin HIV infection",

author = "Jeļena Eglīte and Diāna Kasjko and Vladislavs Jasinskis and Elvīra Hagina and Inga Janu{\v s}kevi{\v c}a and Gunta Stūre and Baiba Rozentāle and Jeļena Storo{\v z}enko and Ludmila Vīksna",

year = "2017",

month = jan,

day = "20",

language = "Latvian",

publisher = "Patent Office of the Republic of Latvia",

type = "Patent",

note = "15 133; G01N33/53,GO1N33/543",

}

TY - PAT

T1 - Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy

AU - Eglīte, Jeļena

AU - Kasjko, Diāna

AU - Jasinskis, Vladislavs

AU - Hagina, Elvīra

AU - Januškeviča, Inga

AU - Stūre, Gunta

AU - Rozentāle, Baiba

AU - Storoženko, Jeļena

AU - Vīksna, Ludmila

PY - 2017/1/20

Y1 - 2017/1/20

N2 - Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy. The method provides for detection of TNFα, IL2, IL4, IL12β, IL10, INFɣ mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.

AB - Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy. The method provides for detection of TNFα, IL2, IL4, IL12β, IL10, INFɣ mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.

KW - prognosing risk of intrauterin HIV infection

UR - https://www.lrpv.gov.lv/sites/lrpv/files/media_file/201606201.pdf

M3 - Patent

M1 - 15 133

Y2 - 2016/03/09

PB - Patent Office of the Republic of Latvia

ER -

Prognosis method of risk of HIV intrauterin foetus infection from HIV infected mother during the first six months of pregnancy

Abstract

Keywords*

Field of Science*

Patent expiration date

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this